[PHARMA] YoY Annualized Quarter Result on 31-Mar-2015 [#1]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
18-May-2015
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2015
Quarter
31-Mar-2015 [#1]
Profit Trend
QoQ- 35.52%
YoY- 21.27%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Annualized Quarter Result
31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 CAGR
Revenue 2,471,692 2,473,176 2,236,780 1,887,616 1,874,688 2,001,356 1,786,980 5.55%
PBT 114,828 111,108 106,152 154,448 152,636 147,696 171,820 -6.49%
Tax -44,472 -34,076 -32,272 -26,744 -46,052 -47,084 -55,576 -3.64%
NP 70,356 77,032 73,880 127,704 106,584 100,612 116,244 -8.02%
-
NP to SH 70,344 75,692 73,516 127,176 104,868 99,084 114,740 -7.82%
-
Tax Rate 38.73% 30.67% 30.40% 17.32% 30.17% 31.88% 32.35% -
Total Cost 2,401,336 2,396,144 2,162,900 1,759,912 1,768,104 1,900,744 1,670,736 6.22%
-
Net Worth 524,838 544,360 515,906 528,173 515,022 484,829 474,161 1.70%
Dividend
31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 CAGR
Div 51,964 41,475 41,417 72,494 41,408 35,303 35,297 6.65%
Div Payout % 73.87% 54.79% 56.34% 57.00% 39.49% 35.63% 30.76% -
Equity
31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 CAGR
Net Worth 524,838 544,360 515,906 528,173 515,022 484,829 474,161 1.70%
NOSH 259,821 259,219 258,859 258,908 258,805 117,676 117,657 14.10%
Ratio Analysis
31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 CAGR
NP Margin 2.85% 3.11% 3.30% 6.77% 5.69% 5.03% 6.51% -
ROE 13.40% 13.90% 14.25% 24.08% 20.36% 20.44% 24.20% -
Per Share
31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 CAGR
RPS 951.31 954.09 864.09 729.07 724.36 1,700.72 1,518.79 -7.49%
EPS 27.08 29.20 28.40 49.12 40.52 84.20 97.52 -19.22%
DPS 20.00 16.00 16.00 28.00 16.00 30.00 30.00 -6.53%
NAPS 2.02 2.10 1.993 2.04 1.99 4.12 4.03 -10.86%
Adjusted Per Share Value based on latest NOSH - 258,908
31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 CAGR
RPS 171.50 171.60 155.20 130.97 130.08 138.86 123.99 5.55%
EPS 4.88 5.25 5.10 8.82 7.28 6.87 7.96 -7.82%
DPS 3.61 2.88 2.87 5.03 2.87 2.45 2.45 6.67%
NAPS 0.3642 0.3777 0.358 0.3665 0.3573 0.3364 0.329 1.70%
Price Multiplier on Financial Quarter End Date
31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 CAGR
Date 30/03/18 31/03/17 31/03/16 31/03/15 31/03/14 29/03/13 30/03/12 -
Price 4.28 4.89 5.76 6.00 4.46 8.26 5.90 -
P/RPS 0.45 0.51 0.67 0.82 0.62 0.49 0.39 2.41%
P/EPS 15.81 16.75 20.28 12.21 11.01 9.81 6.05 17.35%
EY 6.33 5.97 4.93 8.19 9.09 10.19 16.53 -14.77%
DY 4.67 3.27 2.78 4.67 3.59 3.63 5.08 -1.39%
P/NAPS 2.12 2.33 2.89 2.94 2.24 2.00 1.46 6.41%
Price Multiplier on Announcement Date
31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 CAGR
Date 16/05/18 16/05/17 13/05/16 18/05/15 14/05/14 15/05/13 03/05/12 -
Price 4.07 4.72 5.60 6.91 4.70 9.26 5.90 -
P/RPS 0.43 0.49 0.65 0.95 0.65 0.54 0.39 1.63%
P/EPS 15.03 16.16 19.72 14.07 11.60 11.00 6.05 16.36%
EY 6.65 6.19 5.07 7.11 8.62 9.09 16.53 -14.07%
DY 4.91 3.39 2.86 4.05 3.40 3.24 5.08 -0.56%
P/NAPS 2.01 2.25 2.81 3.39 2.36 2.25 1.46 5.47%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment